Article Figures & Data
Figures
- FIGURE 1.
Whole-body PET (A) vs. total-body PET (B). (Reprinted with permission of (31).)
- FIGURE 2.
Photograph of EXPLORER mock-up installed at University of California Davis Medical Center.
- FIGURE 3.
Design drawing for EXPLORER PET/CT scanner. (Courtesy of United Imaging Healthcare.)
- FIGURE 4.
Photograph of mini EXPLORER scanner (left) and maximum-intensity-projection images of 2 frames from dynamic total-body imaging study after injection of 8.5 MBq of 18F-FDG (1/10 standard activity) in 4.6-kg rhesus macaque (right).
- FIGURE 5.
Localization through time-of-flight PET showing effect of improving timing resolution. Better timing resolution translates into higher effective sensitivity due to improved localization of each event.
Jump to section
Related Articles
Cited By...
- Quantitative Total-Body Imaging of Blood Flow with High-Temporal-Resolution Early Dynamic 18F-FDG PET Kinetic Modeling
- Is Long-Axial-Field-of-View PET/CT Cost-Effective? An International Health-Economic Analysis
- Diagnostic Radiopharmaceutical Trial Design: Is It Time to Change Nomenclature?
- Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Current Tools, Techniques, and Uncharted Territories
- Total-Body PET System Designs with Axial and Transverse Gaps: A Study of Lesion Quantification and Detectability
- [11C]Carfentanil PET Whole-Body Imaging of Mu-Opioid Receptors: A First In-Human Study
- Magnetically induced magnetosome chain (MAGiC): A biogenic magnetic-particle-imaging tracer with high performance and navigability
- Sarcolemmal and mitochondrial membrane potentials measured ex vivo and in vivo in the heart by pharmacokinetic modelling of [99mTc]sestamibi
- Quantitative Total-Body Imaging of Blood Flow with High Temporal Resolution Early Dynamic 18F-Fluorodeoxyglucose PET Kinetic Modeling
- Advantages and Challenges of Total-Body PET/CT at a Tertiary Cancer Center: Insights from Sun Yat-sen University Cancer Center
- The Role of Total-Body PET in Drug Development and Evaluation: Status and Outlook
- Clinical Implementation of Total-Body PET in China
- Molecular Imaging of Acute Graft-Versus-Host Disease
- Imaging the master regulator of the antioxidant response in non-small cell lung cancer with positron emission tomography
- Infection Imaging: Focus on New Tracers?
- Impact of human CD8+ T cell senescence on 89Zr radiolabelling and homing properties
- Advances in Detector Instrumentation for PET
- Total-Body PET Multiparametric Imaging of Cancer Using a Voxelwise Strategy of Compartmental Modeling
- Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low 18F-FDG Activity
- Performance Characteristics of the Biograph Vision Quadra PET/CT System with a Long Axial Field of View Using the NEMA NU 2-2018 Standard
- Principles of Tracer Kinetic Analysis in Oncology, Part I: Principles and Overview of Methodology
- Visualizing T-Cell Responses: The T-Cell PET Imaging Toolbox
- The Annual Journal Impact Factor Saga
- Developing a Novel Positronium Biomarker for Cardiac Myxoma Imaging
- Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View
- Quantification of Macrophage-Driven Inflammation During Myocardial Infarction with 18F-LW223, a Novel TSPO Radiotracer with Binding Independent of the rs6971 Human Polymorphism
- A systems-level analysis of dynamic total-body PET data reveals complex skeletal energy metabolism networks in vivo
- Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
- Investigating Low-Dose Image Quality in Whole-Body Pediatric 18F-FDG Scans Using Time-of-Flight PET/MRI
- On the Origin of Hybrid Imaging (perspective on "A Combined PET/CT Scanner for Clinical Oncology" J Nucl Med. 2000;41:1369-1379)
- Small-Animal PET: A Technology That Changed Our Field (perspective on "Performance Evaluation of microPET: A High-Resolution Lutetium Oxyorthosilicate PET Scanner for Animal Imaging" J Nucl Med. 1999;40:1164-1175)
- The Future of Nuclear Medicine, Molecular Imaging, and Theranostics
- Consensus Recommendations on the Use of 18F-FDG PET/CT in Lung Disease
- Detection of incipient pancreatic cancer with novel tumor-specific antibodies in mouse models
- Neuroinflammation PET Imaging: Current Opinion and Future Directions
- The Future of Health Care and the Importance of the Nuclear Medicine Technologist
- Total-Body PET Imaging for up to 30 Days After Injection of 89Zr-Labeled Antibodies
- Total-Body PET and Highly Stable Chelators Together Enable Meaningful 89Zr-Antibody PET Studies up to 30 Days After Injection
- Total-Body Dynamic Reconstruction and Parametric Imaging on the uEXPLORER
- PennPET Explorer: Design and Preliminary Performance of a Whole-Body Imager
- PennPET Explorer: Human Imaging on a Whole-Body Imager
- Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer
- Molecular Imaging: a Novel Tool To Visualize Pathogenesis of Infections In Situ
- 89Zr-oxine labelling and PET imaging shows lung delivery of a cell/gene cancer therapy
- Toward Independent Nuclear Medicine, Molecular Imaging, and Theranostic Programs
- Imaging the Molecular Footprints of the Heart-Brain Axis in Cardiovascular Disease
- Structural and Practical Identifiability of Dual-input Kinetic Modeling in Dynamic PET of Liver Inflammation
- First Human Imaging Studies with the EXPLORER Total-Body PET Scanner
- CD8+ T-Cell Density Imaging with 64Cu-Labeled Cys-Diabody Informs Immunotherapy Protocols
- Development and Evaluation of mini-EXPLORER: A Long Axial Field-of-View PET Scanner for Nonhuman Primate Imaging